White House pushes drug pricing reform amid GSK inhaler price disputes
The White House is urging Congress to pass legislation linking drug prices to international benchmarks despite GOP resistance. Meanwhile, a GSK asthma inhaler price hike is raising patient access concerns, intensifying debates on drug affordability.
· 80d ago
